SG133601A1 - Use of gaboxadol for treating insomnia - Google Patents

Use of gaboxadol for treating insomnia

Info

Publication number
SG133601A1
SG133601A1 SG200704528-9A SG2007045289A SG133601A1 SG 133601 A1 SG133601 A1 SG 133601A1 SG 2007045289 A SG2007045289 A SG 2007045289A SG 133601 A1 SG133601 A1 SG 133601A1
Authority
SG
Singapore
Prior art keywords
gaboxadol
treating insomnia
insomnia
treating
Prior art date
Application number
SG200704528-9A
Inventor
Bjarke Ebert
Jonas Lundahl
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG133601(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SG133601A1 publication Critical patent/SG133601A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
SG200704528-9A 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia SG133601A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18

Publications (1)

Publication Number Publication Date
SG133601A1 true SG133601A1 (en) 2007-07-30

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200704528-9A SG133601A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Country Status (17)

Country Link
EP (1) EP1720547A1 (en)
JP (1) JP2007515415A (en)
KR (1) KR20060103335A (en)
CN (1) CN1893942A (en)
AR (1) AR047154A1 (en)
AU (1) AU2004298313A1 (en)
BR (1) BRPI0415893A (en)
CA (1) CA2550610A1 (en)
EA (1) EA200600989A1 (en)
IL (1) IL176239A0 (en)
IS (1) IS8390A (en)
MX (1) MXPA06006685A (en)
NO (1) NO20063320L (en)
SG (1) SG133601A1 (en)
TW (1) TW200528098A (en)
WO (1) WO2005058313A1 (en)
ZA (1) ZA200602762B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H Acid and base salt forms of gaboxadol
WO2019055369A1 (en) * 2017-09-12 2019-03-21 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of narcolepsy
EP3833351A4 (en) 2018-09-20 2021-10-13 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering
AU2019405489A1 (en) 2018-12-17 2021-06-10 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
WO2021127308A1 (en) 2019-12-18 2021-06-24 Ovid Therapeutics Inc. GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (en) * 1995-07-13 1997-09-25 Max Planck Gesellschaft sleeping pills
JP2004530695A (en) * 2001-05-21 2004-10-07 ハー・ルンドベック・アクチエゼルスカベット Granulated formulation of gaboxadol

Also Published As

Publication number Publication date
AR047154A1 (en) 2006-01-11
TW200528098A (en) 2005-09-01
BRPI0415893A (en) 2007-01-09
ZA200602762B (en) 2007-06-27
MXPA06006685A (en) 2006-08-23
CA2550610A1 (en) 2005-06-30
CN1893942A (en) 2007-01-10
WO2005058313A1 (en) 2005-06-30
AU2004298313A1 (en) 2005-06-30
KR20060103335A (en) 2006-09-28
JP2007515415A (en) 2007-06-14
EP1720547A1 (en) 2006-11-15
IL176239A0 (en) 2006-10-05
IS8390A (en) 2006-03-30
NO20063320L (en) 2006-07-18
EA200600989A1 (en) 2006-10-27

Similar Documents

Publication Publication Date Title
EP1667680A4 (en) Combination methods of treating cancer
IL175351A0 (en) Methods of treating asthma
EP1838714A4 (en) Methods of treating pain
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1613308A4 (en) Novel methods for the treatment of cancer
EP1636359A4 (en) Methods for treating pain
GB0325192D0 (en) Method of use
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1696877A4 (en) Methods for treating pain
GB0324761D0 (en) Use of compounds in therapy
EP1613266A4 (en) Methods of treating pain and compositions for use therefor
EP1677794A4 (en) Methods of treating disorder
IL176239A0 (en) Use of gaboxadol for treating insomnia
EP1653982A4 (en) Treatment of malodour
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
GB0426196D0 (en) Methods of treatment
GB0217493D0 (en) Novel methods of treatment
ZA200606071B (en) Methods of treating asthma
GB0208897D0 (en) New method of treatment
GB0329416D0 (en) Treatment of cancer
GB0221712D0 (en) Methods of treatment
GB0327975D0 (en) Methods of treatment
IL172528A0 (en) Surface treatment of sars-infected lungs
GB2398069B (en) Treatment of ferrous waste